The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases

The Real ◽

Bowel Diseases ◽

OC.12.2 THE REAL-WORLD LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES: A SINGLE CENTER OBSERVATIONAL STUDY

Digestive and Liver Disease ◽

10.1016/s1590-8658(19)30202-6 ◽

2019 ◽

Vol 51 ◽

pp. e109

Author(s):

F.S. Macaluso ◽

A. Croce ◽

R. Orlando ◽

M. Ventimiglia ◽

C. Sapienza ◽

...

Keyword(s):

Observational Study ◽

Real World ◽

Single Center ◽

The Real ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Single Center Observational Study

P703 The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjy222.827 ◽

2019 ◽

Vol 13 (Supplement_1) ◽

pp. S472-S473

Author(s):

F S Macaluso ◽

A Croce ◽

R Orlando ◽

M Ventimiglia ◽

C Sapienza ◽

...

Keyword(s):

Observational Study ◽

Real World ◽

Single Centre ◽

The Real ◽

Bowel Diseases ◽

Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases

Scandinavian Journal of Gastroenterology ◽

10.1080/00365521.2021.1946588 ◽

2021 ◽

pp. 1-9

Author(s):

Mohamed Attauabi ◽

Camilla Höglund ◽

Janne Fassov ◽

Kenneth Bo Pedersen ◽

Heidi Bansholm Hansen ◽

...

Keyword(s):

Elderly Patients ◽

Real World ◽

Biological Therapy ◽

First Line ◽

Bowel Diseases ◽

Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.16478 ◽

2021 ◽

Author(s):

Andreas Blesl ◽

Lukas Binder ◽

Christoph Högenauer ◽

Heimo Wenzl ◽

Andrea Borenich ◽

...

Keyword(s):

Real World ◽

Term Treatment ◽

Treatment Persistence ◽

Long Term Treatment ◽

Bowel Diseases ◽

Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting

International Journal of Colorectal Disease ◽

10.1007/s00384-020-03588-w ◽

2020 ◽

Vol 35 (8) ◽

pp. 1587-1598

Author(s):

B. Bokemeyer ◽

M. Ghiani ◽

A. Fuchs ◽

B. Deiters ◽

F. Hardtstock ◽

...

Keyword(s):

Real World ◽

Steroid Dependency ◽

Real World Setting ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Active Disease

Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases

JGH Open ◽

10.1002/jgh3.12502 ◽

2021 ◽

Vol 5 (3) ◽

pp. 364-370

Author(s):

Anna Viola ◽

Marco Muscianisi ◽

Fabio S Macaluso ◽

Marco Ventimiglia ◽

Maria Cappello ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Real World ◽

Bowel Diseases ◽

T04.01.19 USTEKINUMAB IN CROHN'S DISEASE: REAL-WORLD OUTCOMES FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD) – PRELIMINARY RESULTS

Digestive and Liver Disease ◽

10.1016/s1590-8658(20)30773-8 ◽

2020 ◽

Vol 52 ◽

pp. S125

Author(s):

A. Centritto ◽

G. Fiocco ◽

A. Alibrandi ◽

F.S. Macaluso ◽

M. Cappello ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Real World ◽

Preliminary Results ◽

Bowel Diseases ◽

P407 Real-world safety of tofacitinib in inflammatory bowel diseases: a multi-centre study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjy222.531 ◽

2019 ◽

Vol 13 (Supplement_1) ◽

pp. S312-S313

Author(s):

A Yarur ◽

L Bixuan ◽

P Deepak ◽

A Khatiwada ◽

G Christophi ◽

...

Keyword(s):

Real World ◽

Multi Centre Study ◽

Centre Study ◽

Bowel Diseases ◽

Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

Expert Opinion on Biological Therapy ◽

10.1080/14712598.2020.1830057 ◽

2020 ◽

Vol 20 (11) ◽

pp. 1381-1384

Author(s):

Fabio Salvatore Macaluso ◽

Walter Fries ◽

Anna Viola ◽

Giuseppe Costantino ◽

Marco Muscianisi ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Real World ◽

Real World Data ◽

World Data ◽

Bowel Diseases ◽

797 – Real-World Safety of Tofacitinib in Inflammatory Bowel Diseases: A Multi-Center Study

Gastroenterology ◽

10.1016/s0016-5085(19)37214-2 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-169 ◽

Cited By ~ 1

Author(s):

Parakkal Deepak ◽

Aava Khatiwada ◽

George P. Christophi ◽

Andres J. Yarur ◽

Bixuan Lin ◽

...

Keyword(s):

Real World ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Multi Center Study ◽

Center Study